-
Innovation Ranking
NewInnovation Ranking – Amoy Diagnostics Co Ltd
Amoy Diagnostics Co Ltd (AmoyDx) is a pharmaceutical company that develops molecular diagnostics for oncology precision medicine. The company's product portfolio comprises single-gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems among others. It serves the domestic and international oncology sectors. AmoyDx partners with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene for trials of drugs in clinical development and for clinical practice. The company markets its products through a network of distributors...
-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA Tests market size was $12.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests) are carried out to detect gene rearrangements within blood samples. The outcome of this may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BRAF Tests Market Report Overview The BRAF Tests market size was valued at $32.8 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. BRAF Sanger sequencing Tests are used when complete sequencing of the BRAF gene is required for accurate detection and mapping of mutations. Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs). BRAF Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for More...
-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
The KRAS Market Report Overview The KRAS market size was $37.1 million in 2023. Factors such as product innovation will drive the market growth at a CAGR of more than 7% from 2023 to 2033. KRAS are devices used to inject contrast media agents into a patient's bloodstream. This process enables the visualization of various pathologies through X-ray, computed tomography, magnetic resonance, or other medical imaging devices. CT Injectors, MRI Injectors, and Angiographic Injectors have been included in this category....
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Report Overview The ALK Tests market size was valued at $27.3 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells, the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for...
-
Sector Analysis
Singapore Meat Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Singapore Meat Market Overview The Singapore meat market was valued at SGD2.4 billion ($1.7 billion) in 2022 and is expected to grow at a CAGR of more than 2% during the period 2022-2027. Chilled raw packaged meat - whole cuts was the largest category in 2022. This category is forecast to register the fastest value growth during 2022-2027 as well. Singapore Meat Market Outlook, (SGD Billion, 2022) The Singapore meat market report provides an overview of the overall sector value...
-
Product Insights
Poland EGFR Tests Market Share
EGFR Tests (In Vitro Diagnostics) Poland Market Share report provides quantitative market trends within the In Vitro Diagnostics therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report...